Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis.

Guowei KimHon Lyn TanElya ChenSiok Chin TeoClarisse Jia Min JangJingshan HoYvonne AngNatalie Yan Li NgoiCheng Ean CheeBettina LieskeAsim ShabbirLing-Zhi WangJimmy Bok Yan SoWei Peng Yong

Published in: Pleura and peritoneum (2018)

This phase I study can provide the scientific basis to identify the optimal dose for PIPAC with oxaliplatin such that the benefits of this novel and promising intraperitoneal chemotherapy delivery technique can be maximized.

Keyphrases

study protocol
randomized controlled trial
clinical trial
locally advanced
open label
water soluble